The role of CRAC channel in asthma

Pulmonary Pharmacology & Therapeutics
Manminder KaurDave Singh

Abstract

Asthma is increasing globally and current treatments only manage a proportion of patients. There is an urgent need to develop new therapies. Lymphocytes are thought to play a central role in the pathophysiology of asthma through the production of inflammatory mediators. This is thought to be via the transcription factor NFAT which in turn can be activated through Ca(2+) release-activated Ca(2+) (CRAC) channels. The aim of this work was to investigate the role of CRAC in clinical and pre-clinical models of allergic asthma. Initial data demonstrated that the NFAT pathway is increased in stimulated lymphocytes from asthmatics. To confirm a role for the channel we showed that a selective inhibitor, Synta 66, blocked mediator production from lymphocytes. Synta 66 inhibited CD2/3/28 induced IL-2, IL-7, IL-13 & IFNΥ in a concentration-dependent manner in healthy and severe asthma donors, with over 60% inhibition observed for all cytokines. NFAT pathway was also increased in a pre-clinical asthma model. In this model we have demonstrated that CRAC played a central role in the airway inflammation and late asthmatic response (LAR). In conclusion, our data provides evidence that suggests targeting CRAC channels could be of therapeutic ben...Continue Reading

References

Apr 1, 2000·Australian Family Physician·J Burdon
Feb 13, 2001·The Journal of Clinical Investigation·P J Barnes
Sep 12, 2001·Allergy·R G Stirling, K F Chung
Feb 11, 2004·Current Allergy and Asthma Reports·Marsha Wills-Karp
Nov 18, 2004·Immunological Reviews·Marsha Wills-Karp
Jun 2, 2005·Nature Reviews. Immunology·Fernando Macian
Jun 29, 2005·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Wim A WuytsGeert M Verleden
Feb 13, 2007·The Journal of Biological Chemistry·Yousang GwackAnjana Rao
Sep 28, 2007·Current Medicinal Chemistry·Simonetta BaraldoMarina Saetta
Aug 2, 2008·The Journal of Allergy and Clinical Immunology·Jennifer KearleyClare M Lloyd
Mar 8, 2011·Allergy·L CosmiF Annunziato
Aug 16, 2011·Thorax·Kristof RaemdonckMaria G Belvisi
Mar 14, 2012·The Journal of Allergy and Clinical Immunology·Ian AshmolePeter Bradding
Mar 16, 2012·Respiratory Research·Manminder KaurDave Singh
Apr 13, 2012·The European Respiratory Journal·Dave SinghBrian O'Connor
Dec 12, 2012·Cell Calcium·Isabella DerlerChristoph Romanin
Nov 15, 2013·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·G M GauvreauP M O'Byrne
Jul 22, 2014·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·B R LeakerT MacRury
Aug 7, 2014·The World Allergy Organization Journal·Stephen T Holgate
Dec 4, 2014·International Immunopharmacology·Manminder KaurDave Singh
Jul 29, 2015·Cell Calcium·Patrick G Hogan

❮ Previous
Next ❯

Citations

Sep 24, 2020·Annual Review of Pharmacology and Toxicology·Daniel BakowskiAnant B Parekh
Aug 15, 2021·The Journal of Immunology : Official Journal of the American Association of Immunologists·Timothy S KountzMurali Prakriya

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Asthma

This feed focuses in Asthma in which your airways narrow and swell. This can make breathing difficult and trigger coughing, wheezing and shortness of breath.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.